T cell response to amyloid-β and to mitochondrial antigens in Alzheimer's disease

被引:25
|
作者
Giubilei, F [1 ]
Antonini, G [1 ]
Montesperelli, C [1 ]
Sepe-Monti, M [1 ]
Cannoni, S [1 ]
Pichi, A [1 ]
Tisei, P [1 ]
Casini, AR [1 ]
Buttinelli, C [1 ]
Prencipe, M [1 ]
Salvetti, M [1 ]
Ristori, G [1 ]
机构
[1] Univ Roma La Sapienza, Dipartimento Sci Neurol, I-00185 Rome, Italy
关键词
Alzheimer's disease; amyloid-beta; T lymphocytes; T cell reactivity; mitochondrial antigens;
D O I
10.1159/000069991
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Despite the vast amount of literature on non-specific immune mechanisms in Alzheimer's disease (AD), little is known about the role of antigen-specific immune responses. We investigated T cell reactivity to fragment 1-42 of amyloid-beta (Abeta) and to N-terminal peptides of human mitochondrial and control microbial proteins. Thirty subjects with a diagnosis of probable AD according to NINCDS-ADRDA criteria and 30 sex- and age-matched healthy controls were enrolled. T cell responses to Abeta fragment showed no significant differences between AD patients and controls. By contrast, the mean number of positive T cell responses to both human mitochondrial and microbial peptides was significantly decreased in AD patients compared to control subjects. No significant correlation was found between T cell responses and both the severity of cognitive impairment and duration of the disease. Our results suggest that antigen-specific immune responses are impaired in AD. Protective immune responses to harmful amyloidogenic substances may also be impaired, thus favoring their accumulation in the brain. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 50 条
  • [31] Amyloid-β and Tau at the Crossroads of Alzheimer's Disease
    Gallardo, Gilbert
    Holtzman, David M.
    TAU BIOLOGY, 2019, 1184 : 187 - 203
  • [32] Amyloid-β-targeting immunotherapies for Alzheimer's disease
    Jin, Yi
    Du, Qiaofei
    Song, Mingjie
    Kang, Ruixin
    Zhou, Jianping
    Zhang, Huaqing
    Ding, Yang
    JOURNAL OF CONTROLLED RELEASE, 2024, 375 : 346 - 365
  • [33] Soluble Amyloid-β Consumption in Alzheimer's Disease
    Espay, Alberto J.
    Sturchio, Andrea
    Schneider, Lon S.
    Ezzat, Kariem
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 82 (04) : 1403 - 1415
  • [34] Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet-Mediated Amyloid Aggregation in Alzheimer's Disease
    Donner, Lili
    Feige, Tobias
    Freiburg, Carolin
    Toska, Laura Mara
    Reichert, Andreas S.
    Chatterjee, Madhumita
    Elvers, Margitta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [35] Mitochondrial β-amyloid in Alzheimer's disease
    Borger, Eva
    Aitken, Laura
    Muirhead, Kirsty E. A.
    Allen, Zoe E.
    Ainge, James A.
    Conway, Stuart J.
    Gunn-Moore, Frank J.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 868 - 873
  • [36] Mitochondrial dysfunction and Alzheimer's disease:: role of amyloid-β peptide alcohol dehydrogenase (ABAD)
    Yan, SD
    Stern, DM
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2005, 86 (03) : 161 - 171
  • [37] Interaction between Alzheimer's Amyloid-β and Amyloid-β-Metal Complexes with Cell Membranes
    Suwalsky, Mario
    Bolognin, Silvia
    Zatta, Paolo
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 17 (01) : 81 - 90
  • [38] Leveraging physiological response to detect Alzheimer's disease associated amyloid-β oligomers
    Watson, Brittany E.
    Moss, Melissa A.
    Gonzalez, Francisco
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 538A - 538A
  • [39] Amyloid-β vaccine for Alzheimer disease
    Novak, K
    NATURE MEDICINE, 1999, 5 (08) : 870 - 870
  • [40] Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β
    Castellani, Rudy J.
    Lee, Hyoung-gon
    Siedlak, Sandra L.
    Nunomura, Akihiko
    Hayashi, Takaaki
    Nakamura, Masao
    Zhu, Xiongwei
    Perry, George
    Smith, Mark A.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (02) : 447 - 452